Merit’s embolization products are the best studied on the market and provide efficient and safe administration as well as predictable results. The company offers both Bearing nsPVA® Embolization Particles and Embosphere® microspheres, which are approved for numerous procedures, including the embolization of uterine fibroids (UFE) and the embolization of the prostate artery (PAE). Embosphere® microspheres from Merit have already been used in more than 340,000 procedures and are the subject of more than 120 peer-reviewed clinical articles.
EmboCube® is the only approved pre-cut gel foam for intraarterial injection packaged in a 10 ml syringe for rapid preparation. Depending on the requirements of the procedure, EmboCube® can offer two injection options: Slurry or cubes.
To complete the portfolio, Merit also offers drug releasing embolic HepaSphere™ microspheres for transarterial chemoembolization. In combination with doxorubicin and irinotecan for the treatment of HCC and colorectal metastases in the liver, HepaSphere™ Microspheres offers a variety of treatments. The 10-year literature shows a significant response in the treatment of HCC.
Merit also offers a range of unique and solution-oriented microcatheters, such as the SwiftNINJA®, Maestro® and pursue™. Each device offers a special advantage that allows doctors to achieve their best results.
